证券记录 · 已归档季度
AORT
Artivion, Inc. · Healthcare · Medical - Devices
9被追踪持有人
—Δ持有人
3.19M持有股份
$81.86M报告持仓市值
+0新建仓位
−0清仓
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | -9 | 30.79M | $692.37M | +4 | −14 |
| Q1 2026 | 90 | -2 | 28.88M | $1.06B | +3 | −5 |
| Q4 2025 | 92 | +1 | 30.30M | $1.38B | +1 | — |
| Q3 2025 | 16 | 0 | 19.46M | $824.05M | — | — |
| Q2 2025 | 13 | -1 | 15.74M | $489.42M | — | −1 |
| Q1 2025 | 11 | +2 | 4.47M | $109.76M | +4 | −2 |
| Q4 2024 | 9 | 0 | 4.55M | $130.11M | +2 | −2 |
| Q3 2024 | 8 | -1 | 2.82M | $75.02M | — | −1 |
| Q2 2024 | 9 | — | 3.19M | $81.86M | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 1.61M | — | $41.30M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 1.61M | — | $41.30M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 1.61M | — | $41.30M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 1.61M | — | $41.30M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 1.61M | — | $41.30M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.61M | — | $41.30M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Geode Capital Management ✦ (被动) | 886.02K | — | $22.73M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Geode Capital Management ✦ (被动) | 886.02K | — | $22.73M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Millennium Management ✦ | 486.12K | — | $12.47M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 46.40K | — | $1.19M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 46.17K | — | $1.18M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 45.77K | — | $1.17M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 35.08K | — | $900,000 | 0.0% | n/c | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 21.49K | — | $551,193 | 0.0% | n/c | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 21.49K | — | $551,193 | 0.0% | n/c | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 21.49K | — | $551,193 | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 14.28K | — | $366,205 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 237 持有人, 44.31M 股份, $1.58B 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 19
Mackin James P
Officer · 70.00K 股 · $2.03M
Aug 14
Berry Lance A
Officer · 715 股 · $20,413
Aug 14
GREEN ANDREW M
Officer · 616 股 · $17,586
Aug 12
Holloway Jean F
Officer · 977 股 · $27,835
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G/A — NOMURA ASSET MANAGEMENT INTERNATIONAL…
Aug 06
SC 13G/A — FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓(被追踪范围,变动对比集);内部人行为来自Form 3/4/5;重大持股来自Schedule 13D/13G;所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据